[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2005, 31(1) 15-17 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
��֯����Ƥ��������Ƥ���������Ӧ�� | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
¬��1, ������2, ����3, ������1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. ���ľ�ҽ��ѧ����ҽԺƤ���� ���� 710032; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
Ƥ����֯������ؼ�����չѸ��,��Ƥ�������Ʒ���Ҳ����һЩ����Ӧ�á���������Ƥ��������Ƥ��ȱ����,���������ư��硢�����Ա�Ƥ�ɽ�֢���⻯������Ƥ����������,����Ч�Ϻ�,�Ѿ���ΪƤ�������Ƶ�һ�����㡣 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� ��֯���� Ƥ������ ���� | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. ���ľ�ҽ��ѧ����ҽԺƤ���� ���� 710032; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. ���ľ�ҽ��ѧ����ҽԺƤ���� ���� 710032; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2004-03-05 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1] Lee KH. Tissue-engineered human living skin substitutes:development and clinical application. Yonsei Med J, 2000, 41:774-779. [2] Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev. 2000, (2) :CD001737. [3] Martin LK, Kirsner RS. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol, 2003, 42:402-404. [4] Limat A, French LE, Blal L, et al. Organotypic cultures of autologous hair follicle kcratinocytes for the treatment of recurrent leg ulcers. J Am Acad Dermatol, 2003, 48:207-214. [5] De Luca M, Albanese E, Bondanza S,et al. Multicentre experience in the treatment of bums with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns, 1989, 15:303-309. [6] Oshima H, Inoue H, Matsuzaki K, et al. Permanent restoration of human skintreated with cultured epithelium grafting-wound healing by stem cell based tissue engineering. Hum Cell, 2002, 15:118-128. [7] Gohari S, Gambla C, Healey M,et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg, 2002, 28:1107-1114. [8] Osswald SS, Elston DM, Vogel PS. Giant right plantar keloid treated with excision and tissue-engineered allograft. J Am Acad Dermatol,2003, 48:131-134. [9] Greenberg JE, Falabella AF, Bello YM, et al. Tissue-engineered skin in the healing of wound stumps from limb amputations secondary to purpara fulminans. Pediatr Dermatol, 2003, 20:169-172. [10] Owen CM, Murphy H, Yates VM. Tissue-engineered dermal skin grafting in the treatment of ulcerated necrobiosis lipoidica. Clin Exp Dermatol, 2001, 26:176-178. [11] Maier JP, Lippitt C, Mooney EK. Use of tissue-engineered skin in the dermal atrophy patient with traumatic avulsion injuries. Ann Plast Surg, 2002, 49:67-72. [12] Plott RT, Brysk MM, Newton RC, et al. A surgical treatment for vitiligo:autologous cultured-epithelial grafts. J Dermatol Surg Oncol,1989, 15:1161-1166. [13] van Geel N, Ongenae K, Naeyaert JM. Surgical techniques for vitiligo:a review. Dermatology, 2001, 202:162-166. [14] Arenberger P, Broz L, Vesely P,et al. Tissue-engineered skin in the treatment of vitiligo lesions. Folia Biol (Praha), 2000,46:157-160. [15] Phillips J, Gawkrodger DJ, Caddy CM, et al. Keratinocytes suppress TRP-1 expression and reduce cell number of co-cultured melanocytes-implications for grafting of patients with vitiligo. Pigment Cell Res,2001, 14:116-125. [16] Guerra L, Capurro S, Melchi F,et al. Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts.Arch Dermatol, 2000, 136:1380-1389. [17] Olsson MJ, Juhlin L. Transplantation of melanocytes in vitiligo. Br J Dermatol, 1995, 132:587-591. [18] Chen YF, Chang JS, Yang PY, et al. Transplant of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental vitiligo. J Dermatol, 2000, 27:434-439. [19] Brysk MM, Newton RC, Rajaraman S, et al. Repigmentation of vitiliginous skin by cultured cells. Pigment Cell Res, 1989, 2(3) :202-207. [20] Zachariae H, Zachariae C, Deleuran B, et al. Autotransplantation in vitiligo:treatment with epidermal grafts and cultured melanocytes.Acta Derm Venereol, 1993, 73:46-48. [21] van Geel N, Ongenae K, De Mil M,et al. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo:a pilot study. Dermatol Surg, 2001, 27:873-876. [22] Baier Leach J, Bivens KA, Patrick CW Jr, et al. Photocrosslinked hyaluronic acid hydrogels:natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng, 2003, 82:578-589. [23] Carter DM, Lin AN, Varghese MC, et al. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol,1987, 17:246-250. [24] Falabella AF, Schachner LA, Valencia IC, et al. The use of tissueengineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol, 1999, 135:1219-1222. [25] Falabella AF, Valencia IC, Eaglstein WH, et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol, 2000,136:1225-1230. [26] Banta MN, Kirsner RS. Modulating diseased skin with tissue engineering:actinic purpura treated with Apligraf. Dermatol Surg, 2002,28:1103-1106. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1����Ծ��, ����.��֯����Ƥ�����ٴ�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2007,33(6): 340-342 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
2����Ծ��, ����.��֯����Ƥ�����ٴ�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 0,(): 340-342 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |